P J Meikle

Summary

Affiliation: University of Adelaide
Country: Australia

Publications

  1. ncbi Prevalence of lysosomal storage disorders
    P J Meikle
    Department of Chemical Pathology, Women s and Children s Hospital, Adelaide, Australia
    JAMA 281:249-54. 1999
  2. ncbi Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker
    P J Meikle
    Department of Chemical Pathology, Women s and Children s Hospital, North Adelaide, Australia
    Clin Chem 43:1325-35. 1997
  3. ncbi Newborn screening for lysosomal storage disorders
    P J Meikle
    Department of Chemical Pathology, Women s and Children s Hospital, North Adelaide, Australia
    Southeast Asian J Trop Med Public Health 30:104-10. 1999
  4. ncbi Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease
    K Umapathysivam
    Lysosomal Diseases Research Unit, Department of Chemical Pathology, Women's and Children's Hospital, 72 King William Rd, North Adelaide, South Australia 5006, Australia
    Clin Chem 47:1378-83. 2001
  5. ncbi Mass spectrometry in the study of lysosomal storage disorders
    P J Meikle
    Lysosomal Diseases Research Unit, Department of Chemical Pathology, Women s and Children s Hospital, 72 King William Road, North Adelaide, SA 5006, Australia
    Cell Mol Biol (Noisy-le-grand) 49:769-77. 2003

Collaborators

Detail Information

Publications5

  1. ncbi Prevalence of lysosomal storage disorders
    P J Meikle
    Department of Chemical Pathology, Women s and Children s Hospital, Adelaide, Australia
    JAMA 281:249-54. 1999
    ..To date, no comprehensive study has been performed on the prevalence of these disorders as a group...
  2. ncbi Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker
    P J Meikle
    Department of Chemical Pathology, Women s and Children s Hospital, North Adelaide, Australia
    Clin Chem 43:1325-35. 1997
    ..Overall, 72% of patients had LAMP-1 concentrations above the 95th percentile of the unpartitioned control population. We suggest that LAMP-1 may be a useful marker in newborn screening for LSDs...
  3. ncbi Newborn screening for lysosomal storage disorders
    P J Meikle
    Department of Chemical Pathology, Women s and Children s Hospital, North Adelaide, Australia
    Southeast Asian J Trop Med Public Health 30:104-10. 1999
    ....
  4. ncbi Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease
    K Umapathysivam
    Lysosomal Diseases Research Unit, Department of Chemical Pathology, Women's and Children's Hospital, 72 King William Rd, North Adelaide, South Australia 5006, Australia
    Clin Chem 47:1378-83. 2001
    ..With further validation, this procedure could be adapted for use with blood spots collected in newborn-screening programs...
  5. ncbi Mass spectrometry in the study of lysosomal storage disorders
    P J Meikle
    Lysosomal Diseases Research Unit, Department of Chemical Pathology, Women s and Children s Hospital, 72 King William Road, North Adelaide, SA 5006, Australia
    Cell Mol Biol (Noisy-le-grand) 49:769-77. 2003
    ..We will discuss progress in the field, limitations of current methods, and summarise issues relating to the diagnosis and treatment of some of the more prevalent lysosomal storage disorders...